Joseph Constance[email protected]Prostate CancerMan's best friend helps train neural network for prostate cancerResearchers with Medical Detection Dogs of the U.K. studied the olfactory ability of dogs to detect aggressive prostate cancer from urine samples and used it to train an artificial neural network (ANN) to better detect cancer in diagnostics. They found that the cancer-sniffing ability of the canines was just one of several factors that could be used to optimize their neural network.February 17, 2021Pathology, histologyPICC initiative hopes to standardize digital pathologyStepping up to the plate to fill this void is the Pathology Innovation Collaborative Community (PICC), an open forum that aims to unlock the full potential of digital pathology by accelerating the development and delivery of regulatory science-based initiatives in the precompetitive (premarket) space.January 31, 2021CollaborationHexapod personal protective booths cut testing costs for COVID-19The booths have been developed at Massachusetts General Hospital and Partners HealthCare, now the Mass General Brigham integrated healthcare system, which collaborated in their design and construction. The booths could be adapted for use in clinical laboratories.January 18, 2021Pathology, histologyAI opportunities abound in clinical labs -- but prep work is keyMachine learning uses statistics to find patterns in extensive amounts of data. Machine learning can mine medical data to find cures for diseases, diagnose patients before they become ill, and better personalize diagnostics and therapeutics. Data analytics opportunities in the clinical lab abound and include diagnosis, prognosis, and test menu optimization.December 21, 2020COVID-19Quick decisions, expertise kept Wash. lab afloat during 1st COVID-19 hotspotThe university's Medicine Clinical Virology Lab recently processed its 1 millionth COVID-19 specimen, eight months after the SARS-CoV-2 pandemic began in the state of Washington. This milestone was significant for the Seattle-area community, as well as the faculty and staff who work in the university's department of laboratory medicine and pathology.December 17, 2020InfluenzaCOVID-19 challenges the landscape of rapid testing for infectious diseasesThe COVID-19 pandemic has changed the rapid testing landscape, according to Nikolina Babic, PhD, of the department of pathology and laboratory medicine at the Medical University of South Carolina in Charleston.December 16, 2020Bipolar DisorderLow-volume test platform from Baebies wins 'disruptive tech' award at AACCIn the third annual edition of the Disruptive Technology Award competition, Baebies won the award for Finder, a near-patient testing platform featuring a toaster-sized instrument and disposable cartridge. Powered by digital microfluidics technology, Baebies' Finder tests for diseases using low sample volumes with a turnaround time of approximately 15 minutes after sample introduction.December 14, 2020COVID-19Assay for early diagnosis of COVID-19 key to controlling pandemicEssentially, microbiologists at the University of Hong Kong and colleagues elsewhere found that detecting anti-orf8 antibodies is more sensitive and accurate than the conventional antinucleoprotein (anti-N) antibody detection used in identifying COVID-19 patients especially during the early stage of infection.October 25, 2020Point-of-Care TestingD-dimer test alone can simplify diagnosis of DVTCurrent guidelines for diagnosing DVT are complicated, time-consuming, and could be challenging to undertake in busy hospital emergency departments. The guidelines incorporate clinical pretest probability (C-PTP) assessments, D-dimer results, and compression ultrasound (CUS).October 15, 2020Pathology, histologyTelepathology: Part 2 -- Putting plans into actionThe effort to transition to a digital workflow and telepathology started in 2014 at the University of California, San Francisco School of Medicine, explained Dr. Zoltan Laszik, professor of clinical pathology and director of digital pathology. The university operates three hospitals and a lab with a staff of approximately 50 pathologists.April 27, 2020Previous PagePage 3 of 6Next PageTop StoriesValidationImmunovia announces positive results for next-gen pancreatic cancer testDiagnostics company Immunovia announced positive results for the newest generation of its pancreatic cancer test from a model-development study, announcing that the test achieved both its primary and secondary endpoints.CollaborationVertex to pay $25M upfront to scale cell manufacturing technologyLawsuitU.K. Patents Court rules Bio-Techne patents invalid in infringement lawsuitPoint-of-Care TestingScout secures CARB-X grant to advance diagnostic test developmentSponsor ContentVisit our Molecular Diagnostics Community